Submitted by Anonymous (not verified) on 19 November 2024 - 13:53
Orphan designation: glecirasib Treatment of pancreatic cancer, 10/11/2024 Positive
Source:
Orphan designation: glecirasib Treatment of pancreatic cancer, 10/11/2024 Positive